Lok Sabha Question No. 259 (STARRED), answered on 2018-12-28
Subject: Procurement of AYUSH Medicines under CGHS
Ministry: HEALTH AND FAMILY WELFARE
Asked by: SATISH CHANDRA DUBEY

## GOVERNMENT OF INDIA MINISTRY OF HEALTH AND FAMILY WELFARE DEPARTMENT OF HEALTH AND FAMILY WELFARE

## LOK SABHA STARRED QUESTION NO. 259 TO BE ANSWERED ON THE 28 TH DE C EMBER ,2018 PROCUREMENT OF AYUSH MEDICINES UNDER CGHS

## †*259. SHRI SATISH CHANDRA DUBEY:

Will  the  Minister  of  HEALTH  AND  FAMILY  WELFARE  be  pleased  to state:

- (a) whether it is a fact that due to the complicated procurement process of medicines under CGHS, the beneficiaries have to face great difficulties;
- (b) if so, the details thereo f;
- (c)  the  allocation  of  funds  and  expenditure  for  Ayurveda,  Siddha,  Unani Homoeopathy medicines, separately, during the last two years, year - wise; and
- (d) the details of corrective measures taken to hasten the procurement process ease the problems of the patients?

## ANSWER THE MINISTER OF HEALTH AND FAMILY WELFARE (SHRI JAGAT PRAKASH NADDA)

- (a)to ( d) : A Statement is laid on the Table of the House.

## STATEMENT REFERRED TO IN REPLY TO LOK SABHA STARRED QUESTION NO. 259* FOR 28 TH DECEMBER , 20 18

- (a)  &  (b):  Some  difficulties  are  being  faced  by  the  beneficiaries  not of the complex process but because of: -
- i. Non - availability of Authorized Local Chemist for AYUSH in Cities outside Delhi.
- ii. Non - availability of Rate Contract for AYUSH drugs.
- (c): The  details of the funds allocated and spent for  the procurement  of Ayurvedic, Siddha, Unani and Homeopath ic Medicines under CGHS during the last two years are as under: -

## (Rupees in Crores)

|            | 2016- 17   | 2016- 17    | 2017- 18   | 2017- 18    |
|------------|------------|-------------|------------|-------------|
|            | Allotment  | Expenditure | Allotment  | Expenditure |
| Ayurvedic  | 5.44       | 3.07        | 5.44       | 4.59        |
| Unani      | 1.50       | 0.78        | 1.50       | 0.78        |
| Homeopathy | 1.50       | 0.29        | 1.50       | 0.25        |
| Siddha     | 1.00       | 0.35        | 1.00       | 0.45        |

- (d): Followingcorrective measures have been taken to hasten the procurement process and ease the problems of the beneficiaries:
- i. New AyurvedicFormulary has been prepared for 2017 - 19 under which 221 Generic medicines are procured from Indian Medicin Pharmaceutical Corporation Limited (IMPCL) directly and 15 medicines (not manufactured by IMPCL -called non - IMPCL medicines)  are  procured  from  Go vernment/PSU  pharmacies through rate contract and 84 Rogadhikara (disease group identified) Ayur medicines are procured through open tender/rate contract.
- ii. Procurement process has been initiated for 150 non - IMPCL  generic medicines.
- iii. Contract has been awarded through e - tender for procurement of 36 non -IMPCL  generic  Unani  medicines. Process  has  been  initiated  for procurement of branded/disease based/non - formulary Unani Medicines through e - tender.
- iv. E-tender process has been initiated fo r procurement of Homoeopathic formulary medicines.
- v. E-tender  process has been initiated for procurement formulary medicines .

of

Si

- vi. Medicines,  which  are  not  readily  available  in  stock  are  pro through  Authorized  Local  Chemists  (ALCs)  attached  with those dispensaries.
- vii. In c ities,  where  there  are  no  ALCs,  CGHS  beneficiaries  can  buy non- available medicines from open market and claim reimbursement.

*****